| Steven E Tooze, MD | |
|
285 Beiser Blvd Ste 201, Dover, DE 19904-7804 | |
| (302) 731-2888 | |
| (302) 731-7049 |
| Full Name | Steven E Tooze |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 45 Years |
| Location | 285 Beiser Blvd Ste 201, Dover, Delaware |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427051226 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | CI0002468 (Delaware) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bayhealth Hospital, Kent Campus | Dover, DE | Hospital |
| Bayhealth Hospital, Sussex Campus | Milford, DE | Hospital |
| Christiana Hospital | Newark, DE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| First State Orthopaedics Pa | 6103800057 | 69 |
News Archive
A Center For Global Development "Global Health Policy" blog post reports that the World Bank this week "brought a distinguished group together to discuss new findings, evaluation approaches and policy implications" of conditional cash transfer (CCT) programs, writing "Although 75 percent of published evaluations on CCT programs are sourced from Latin America, newer CCT programs in Burkina Faso, Cambodia, Indonesia, Malawi, Pakistan, Tanzania and Nigeria are beginning to document, analyze and report results."
Researchers at National Jewish Health have discovered a fundamental step in the development of the immune system, one that allows B cells to mature and fight disease by producing effective antibodies. Immunologist Roberta Pelanda, PhD, and her colleagues have demonstrated that immature B cells in the bone marrow must receive a positive signal before they can migrate to the spleen where they mature and are activated. In the March 15, 2010 issue of The Journal of Experimental Medicine, the researchers also reported that a protein known as Erk helps deliver that positive signal.
Argos Therapeutics Inc., an immuno-oncology company focused on the development and commercialization of fully individualized immunotherapies for the treatment of cancer based on the Arcelis technology platform, today announced the initiation of a single-center pilot clinical trial of AGS-003 as a neoadjuvant immunotherapy in patients with localized renal cell carcinoma.
The University of Texas MD Anderson Cancer Center and Sanofi today announced a five-year strategic collaboration to accelerate the development of investigational treatments, including targeted and immune therapies, for patients with cancer.
Whether the goal is to separate different types of cells or molecules, methods that rely on the age-old principle of magnetism are a staple among researchers.
› Verified 2 days ago
| Entity Name | First State Orthopaedics Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346220266 PECOS PAC ID: 6103800057 Enrollment ID: O20040617000139 |
News Archive
A Center For Global Development "Global Health Policy" blog post reports that the World Bank this week "brought a distinguished group together to discuss new findings, evaluation approaches and policy implications" of conditional cash transfer (CCT) programs, writing "Although 75 percent of published evaluations on CCT programs are sourced from Latin America, newer CCT programs in Burkina Faso, Cambodia, Indonesia, Malawi, Pakistan, Tanzania and Nigeria are beginning to document, analyze and report results."
Researchers at National Jewish Health have discovered a fundamental step in the development of the immune system, one that allows B cells to mature and fight disease by producing effective antibodies. Immunologist Roberta Pelanda, PhD, and her colleagues have demonstrated that immature B cells in the bone marrow must receive a positive signal before they can migrate to the spleen where they mature and are activated. In the March 15, 2010 issue of The Journal of Experimental Medicine, the researchers also reported that a protein known as Erk helps deliver that positive signal.
Argos Therapeutics Inc., an immuno-oncology company focused on the development and commercialization of fully individualized immunotherapies for the treatment of cancer based on the Arcelis technology platform, today announced the initiation of a single-center pilot clinical trial of AGS-003 as a neoadjuvant immunotherapy in patients with localized renal cell carcinoma.
The University of Texas MD Anderson Cancer Center and Sanofi today announced a five-year strategic collaboration to accelerate the development of investigational treatments, including targeted and immune therapies, for patients with cancer.
Whether the goal is to separate different types of cells or molecules, methods that rely on the age-old principle of magnetism are a staple among researchers.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Steven E Tooze, MD 211 Executive Dr Ste 11, Newark, DE 19702-3358 Ph: (302) 731-2888 | Steven E Tooze, MD 285 Beiser Blvd Ste 201, Dover, DE 19904-7804 Ph: (302) 731-2888 |
News Archive
A Center For Global Development "Global Health Policy" blog post reports that the World Bank this week "brought a distinguished group together to discuss new findings, evaluation approaches and policy implications" of conditional cash transfer (CCT) programs, writing "Although 75 percent of published evaluations on CCT programs are sourced from Latin America, newer CCT programs in Burkina Faso, Cambodia, Indonesia, Malawi, Pakistan, Tanzania and Nigeria are beginning to document, analyze and report results."
Researchers at National Jewish Health have discovered a fundamental step in the development of the immune system, one that allows B cells to mature and fight disease by producing effective antibodies. Immunologist Roberta Pelanda, PhD, and her colleagues have demonstrated that immature B cells in the bone marrow must receive a positive signal before they can migrate to the spleen where they mature and are activated. In the March 15, 2010 issue of The Journal of Experimental Medicine, the researchers also reported that a protein known as Erk helps deliver that positive signal.
Argos Therapeutics Inc., an immuno-oncology company focused on the development and commercialization of fully individualized immunotherapies for the treatment of cancer based on the Arcelis technology platform, today announced the initiation of a single-center pilot clinical trial of AGS-003 as a neoadjuvant immunotherapy in patients with localized renal cell carcinoma.
The University of Texas MD Anderson Cancer Center and Sanofi today announced a five-year strategic collaboration to accelerate the development of investigational treatments, including targeted and immune therapies, for patients with cancer.
Whether the goal is to separate different types of cells or molecules, methods that rely on the age-old principle of magnetism are a staple among researchers.
› Verified 2 days ago
Dr. J Hamilton Easter Jr., M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 720 S Queen St, Dover, DE 19904 Phone: 302-735-8705 Fax: 302-735-8703 | |
John Robert Burger, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 655 S Bay Rd Ste 1f, Dover, DE 19901 Phone: 302-730-4366 Fax: 302-730-0231 | |
Jonathan L Kates, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 540 S Governors Ave, Suite 201, Dover, DE 19904 Phone: 302-730-4366 Fax: 302-730-0231 | |
Stephen L Malone, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 260 Beiser Blvd, Suite 101, Dover, DE 19904 Phone: 302-734-9700 Fax: 302-734-9702 | |
Dr. Andrew Joseph Gambone, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 655 S Bay Rd Ste 1f, Dover, DE 19901 Phone: 302-730-4366 Fax: 302-730-0231 | |
Lawrence Piccioni, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 260 Beiser Blvd, Suite 101, Dover, DE 19904 Phone: 302-730-8060 Fax: 302-730-8063 |